Search
for
Sort by
Research 241–270 of 1000+
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Ecklonia cava promotes hair growth
- Enhancing dermatology clinical trials: optimizing sites and strategies for success in India
- Topically applied glycyrrhizic acid causes hair removal in rats
- Genotype–Phenotype Correlation in Children With Congenital Adrenal Hyperplasia due to 21‐Hydroxylase Deficiency Using Next Generation Sequencing
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Sodium chloride reduces growth and cytosolic calcium, but does not affect cytosolic pH, in root hairs of Arabidopsis thaliana L.
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Synergistic Protective Effect of Finasteride and Black Soybean Extract against Dihydrotestosterone-Induced Damage in Human Follicle Dermal Papilla Cells
- Serum Vitamin D Level in Pediatric Alopecia Areata
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Is the severity of alopecia areata associated with arterial stiffness?
- Extracellular matrix sensing by FERONIA and Leucine‐Rich Repeat Extensins controls vacuolar expansion during cellular elongation in <i>Arabidopsis thaliana</i>
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Two Hydroxyproline Galactosyltransferases, GALT5 and GALT2, Function in Arabinogalactan-Protein Glycosylation, Growth and Development in Arabidopsis
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Effects of AiQingHua oil on microcirculation disturbance and alopecia mice model
- Serum brain‐derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case–control study
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Intralesional methotrexate in patchy alopecia areata: trichoscopic evaluation and effect on lesional tumour necrosis factor alpha
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children